Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 11, Novembre 2003
Page(s) 1121 - 1127
Section M/S Revues
DOI https://doi.org/10.1051/medsci/200319111121
Publié en ligne 15 novembre 2003
  1. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocrinol Rev 1999; 20: 435–59.
  2. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors:mechanisms of mutual antagonism. Mol Endocrinol 1998; 12: 45–56.
  3. Auphan N, DiDonato JA, Rosette C, Helmberg A,Karin M.Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–90.
  4. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA,Baldwin AS Jr.Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.Mol Cell Biol 1995;15: 943–53.
  5. Schouten GJ, van der Eb AJ, Zantema A. Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A. EMBO J 1995; 14: 1498–507.
  6. Heck S, Bender K, Kullmann M, et al. I kappaB alpha-independent downregulation of NF-kappa B activity by glucocorticoid receptor. EMBO J 1997; 16: 4698–707.
  7. Brostjan C, Anrather J, Csizmadia V, et al.Glucocorticoid-mediated repression of NF-kappa B activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996;271: 19612–6.
  8. De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of antiinflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 2000;109: 16–22.
  9. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752–6.
  10. Baes M, Castelein H, Desmet L, Declercq PE. Antagonism of COUP-TF and PPAR alpha/RXR alpha on the activation of the malic enzyme gene promoter:modulation by 9-cis RA. Biochem Biophys Res Commun 1995;215: 338–45.
  11. Ikeda Y, Sugawara A, Taniyama Y, et al.Suppression of rat thromboxane synthase gene transcription by peroxisome proliferatoractivated receptor gamma in macrophages via an interaction with NRF2. J Biol Chem 2000;275: 33142–50.
  12. Sheppard KA, Phelps KM, Williams AJ, et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappa B signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 1998;273: 29291–4.
  13. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.Cell 1996; 85: 403–14
  14. McKay LI, Cidlowski JA. CBP (CREB binding protein)integrates NF-kappa B (nuclear factor-kappa B)and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000; 14: 1222–34.
  15. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98: 6865–70.
  16. Supakar PC, Jung MH, Song CS, Chatterjee B, Roy AK. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the agedependent desensitization of the liver. J Biol Chem 1995; 270: 837–42.
  17. Kalkhoven E, Wissink S, van der Saagn PT, van der Burg B. Negative interaction between the RelA(p65)subunit of NF-kappa B and the progesterone receptor. J Biol Chem 1996;271: 6217–24.
  18. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 betaestradiol:inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997; 409: 79–85.
  19. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15: 4971–9.
  20. Staels B, Koenig W, Habib A, et al. Activation of human aortic smoothmuscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998; 393: 790–3.
  21. Delerive P, De Bosscher K, Besnard S, et al.Peroxisome proliferatoractivated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NFkappaB and AP-1. J Biol Chem 1999;274: 32048–54.
  22. Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21: 1271–9.
  23. Darby TG, Meissner JD, Ruhlmann A, Mueller WH, Scheibe RJ. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene 1997;15: 3067–82.
  24. Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 1991;66: 831–4.
  25. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266–72.
  26. Schule R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991; 88: 6092–6.
  27. Schule R, Evans RM. Crosscoupling of signal transduction pathways:zinc finger meets leucine zipper. Trends Genet 1991;7: 377–81.
  28. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: downmodulation of AP-1(Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189–204.
  29. Yang-Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor:mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;2: 1205–15.
  30. Nicholson RC, Mader S, Nagpal S, et al. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 1990;9: 4443–54.
  31. Zhang XK, Wills KN, Husmann M, Hermann T, Pfahl M. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 1991; 11: 6016–25.
  32. Doucas V, Spyrou G, Yaniv M. Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO J 1991;10: 2237–45.
  33. Schule R, Umesono K, Mangelsdorf DJ, et al. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990; 61: 497–504.
  34. Lucibello FC, Slater EP, Jooss KU, Beato M, Muller R. Mutual transrepression of Fos and the glucocorticoid receptor:involvement of a functional domain in Fos which is absent in FosB. EMBO J 1990; 9: 2827–34.
  35. Wagner S, Green MR. DNA-binding domains: targets for viral and cellular regulators. Curr Opin Cell Biol 1994; 6: 410–4.
  36. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 1999; 13: 1398–411.
  37. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 1999; 96: 8705–10.
  38. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000; 95: 2543–51.
  39. Lee SK, Kim HJ, Na SY, et al. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem 1998; 273: 16651–4.
  40. De Bosscher K, Vanden Berghe W, Haegeman G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol Endocrinol 2001; 15: 219–27.
  41. Zhou XF, Shen XQ, Shemshedini L. Ligandactivated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 1999; 13: 276–85.
  42. Caelles C, Gonzalez-Sancho JM, Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 1997; 11: 3351–64.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.